SAFETY AND EFFICACY OF THE PD‐L1 INHIBITOR DURVALUMAB WITH R‐CHOP OR R2‐CHOP IN SUBJECTS WITH PREVIOUSLY UNTREATED, HIGH‐RISK DLBCL. (12th June 2019)

• Record Type: Journal Article
• Authors: Nowakowski, G.; Willenbacher, W.; Greil, R.; Larsen, T.S.; Patel, K.; Jäger, U.; Manges, R.F.; Trümper, L.; Haioun, C.; Everaus, H.; Kalakonda, N.; Knoble, J.; de Nully Brown, P.; Jørgensen, J.M.; Cunningham, D.; Domper Rubio, N.; Casadebaig, M.; Manzke, O.; Munoz, J.
• Is Part Of: Hematological oncology. Volume 37(2019)Supplement 2
• Page Start: 132
• Page End: 134
• Publication Date: 2019-06-12
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.93_2629
• Languages: English
• ISSNs: 0278-0232